HOUSTON, Oct. 24 (UPI) -- Personalized therapies should be developed to target specific subtypes of lung cancer, researchers concluded in a study.
The study was conducted by scientists at the University of Texas Anderson Cancer. The authors examined molecular data from over 1,000 non-small cell lung cancers, and organized those cases into distinct classifications. Their findings were published in the journal Oncogene.